WS #11999

20:00→20:22 UTC

From 500 msgs · 10 key-dev

Erasca announces $500M common stock offering and updated Phase 1 data for ERAS-0015 with 57% uORR in pancreatic cancer; plans registration-enabling trials.

Erasca $500M Stock Offering and Clinical Data

Erasca announces $500M common stock offering and updated Phase 1 data for ERAS-0015 with 57% uORR in pancreatic cancer; plans registration-enabling trials.

Full world state #11999 →